Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial.
Luis Ricardo Balleza AlejandriFernando Grover PáezErick González CamposCarlos G Ramos BecerraErnesto Germán Cardona MuñózSara Pascoe GonzálezMaría Guadalupe Ramos ZavalaAfrica Samantha Reynoso RoaDaniel O Suarez RicoAlberto Beltrán RamírezJesús Jonathan García GalindoDavid Cardona MüllerClaudia Yanette Galán RuízPublished in: Journal of cardiovascular development and disease (2024)
After the treatment period, the empagliflozin and dapagliflozin groups achieved similar FMD, suggesting a class effect.